Boston, MA -- (SBWIRE) -- 08/17/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Amarin Corporation plc (ADR) (NASDAQ:AMRN), DURECT Corporation (NASDAQ:DRRX), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Endo Health Solutions Inc (NASDAQ:ENDP)
Amarin Corporation plc (ADR) (NASDAQ:AMRN) closed yesterday at $ 6.00, up 3.09%, on volume of over 6.22 million shares. AMRN went up 3.09% in the last 5 days. AMRN average trading volume is 4.02 million shares.In the time frame of the last one month, shares of Amarin Corporation,surged Almost 8.5%. Its market capitalization was $1.03 billion. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid.
For How Long AMRN will Fight for Profitability? Read This Trend Analysis report
DURECT Corporation (NASDAQ:DRRX) ended previous trading at $1.23, gaining 17.14%, with almost 6.04 million shares traded. In the last 5 days DRRX showed a recovery of 18.27% and on its one month graph, shares of DRRX are 6.03% up. The stock has a 52-week high price of $1.85 and its 52-week low was recorded at $0.61. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development.
For How Long DRRX Gloss will Attract Investors? Find out via this report
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) finished trading previously at $40.06, losing -0.12%. Trading volume recorded almost 4.74 million shares as compared to its average volume of 3.84 million shares.Shares of TEVA declined almost -0.12% in the last one month while its 52 week high is $42.83. TEVA has the total of 4.74 billion outstanding shares while its market capitalization was $845.00 million. Teva Pharmaceutical Industries Ltd (Teva) is an Israel-based pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect.
Why Should Investors Buy TEVA After the Recent Fall? Just Go Here and Find Out
Endo Health Solutions Inc (NASDAQ:ENDP) closed yesterday at $ 36.81, down -2.44%, on volume of over 2.21 million shares. ENDP average trading volume is 2.21 million shares. In the time frame of the last one month, shares of Endo Health, dropped Almost -2.44%. Its market capitalization was $4.20 billion. Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm , Opana ER, Voltaren Gel, Percocet , Frova , Supprelin LA, Vantas , Valstar and Fortesta Gel.
Will ENDP Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)